Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: /Content/ Disallow: /Files/ Sitemap: |
Title | ENHERTU® (fam-trastuzumab deruxtecan-nxki) | Official Patient |
Description | ENHERTU is FDA-approved for the treatment of several types of Learn more about ENHERTU® (fam-trastuzumab deruxtecan-nxki) for several types of cancer. See Full Safety and Boxed WARNINGS for more |
Keywords | N/A |
WebSite | enhertu.com |
Host IP | 40.118.104.64 |
Location | United States |
Site | Rank |
US$33,970,431
Last updated: 2023-05-07 19:43:36
enhertu.com has Semrush global rank of 311,574. enhertu.com has an estimated worth of US$ 33,970,431, based on its estimated Ads revenue. enhertu.com receives approximately 3,919,666 unique visitors each day. Its web server is located in United States, with IP address 40.118.104.64. According to SiteAdvisor, enhertu.com is safe to visit. |
Purchase/Sale Value | US$33,970,431 |
Daily Ads Revenue | US$31,358 |
Monthly Ads Revenue | US$940,720 |
Yearly Ads Revenue | US$11,288,636 |
Daily Unique Visitors | 261,312 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
enhertu.com. | A | 3598 | IP: 40.118.104.64 |
enhertu.com. | NS | 86400 | NS Record: ns4.markmonitor.com. |
enhertu.com. | NS | 86400 | NS Record: ns3.markmonitor.com. |
enhertu.com. | NS | 86400 | NS Record: ns1.markmonitor.com. |
enhertu.com. | NS | 86400 | NS Record: ns6.markmonitor.com. |
enhertu.com. | NS | 86400 | NS Record: ns7.markmonitor.com. |
enhertu.com. | NS | 86400 | NS Record: ns2.markmonitor.com. |
enhertu.com. | NS | 86400 | NS Record: ns5.markmonitor.com. |
enhertu.com. | TXT | 3600 | TXT Record: google-site-verification=vtJpj84Qqe2FR6-2JIXft-yFCjm1b2BEkhNVGaKh-04 |
This site is intended for US residents 18 years of age or older. Important Safety Information Prescribing Information Medication Guide Healthcare Professional Site Treatment Access MENU CLOSE Important Safety Information Prescribing Information Medication Guide Healthcare Professional Site Treatment Access This site is intended for US residents 18 years of age or older. ENHERTU is FDA-approved for the treatment of several types of cancer ENHERTU is FDA-approved for the treatment of several types of cancer HER2+ Metastatic Breast Cancer If you were diagnosed with HR+ HER2-negative or triple-negative ( HR– HER2-negative ) mBC, you may actually have low levels of HER2. Learn more below If you were diagnosed with HR+ HER2-negative or triple-negative ( HR– HER2-negative ) mBC, you may actually have low levels of HER2. Learn more below HER2-Low Metastatic Breast Cancer HER2+ Advanced Stomach Cancer HER2-Mutant Metastatic Lung Cancer Scroll for more Don’t know your HER2 status? Talk to your |
HTTP/1.1 301 Moved Permanently Content-Type: text/html Content-length: 0 Connection: Close Location: https://www.enhertu.com/ HTTP/1.1 200 OK Cache-Control: no-cache, no-store Pragma: no-cache Content-Length: 45377 Content-Type: text/html; charset=utf-8 Expires: -1 Server: Microsoft-IIS/10.0 X-Frame-Options: SAMEORIGIN Date: Thu, 28 Oct 2021 15:30:46 GMT |
Domain Name: ENHERTU.COM Registry Domain ID: 2183790014_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2020-11-02T10:39:40Z Creation Date: 2017-11-06T02:31:20Z Registry Expiry Date: 2025-11-06T02:31:20Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895740 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS1.MARKMONITOR.COM Name Server: NS2.MARKMONITOR.COM Name Server: NS3.MARKMONITOR.COM Name Server: NS4.MARKMONITOR.COM Name Server: NS5.MARKMONITOR.COM Name Server: NS6.MARKMONITOR.COM Name Server: NS7.MARKMONITOR.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-16T07:42:13Z <<< |